CO1 A Balancing Act: Low-Dose Atropine Significantly Slows Pediatric Myopia Progression Without a Clinically Meaningful Risk of Rebound (Accelerated Myopia Progression Following Treatment Cessation)
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.104
https://www.valueinhealthjournal.com/article/S1098-3015(25)02661-0/fulltext
Title :
CO1 A Balancing Act: Low-Dose Atropine Significantly Slows Pediatric Myopia Progression Without a Clinically Meaningful Risk of Rebound (Accelerated Myopia Progression Following Treatment Cessation)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)02661-0&doi=10.1016/j.jval.2025.09.104
First page :
Section Title :
Open access? :
No
Section Order :
11370